Dr. Marc Matrana, MD
Claim this profileOchsner Medical Center Jefferson
Expert in Cancer
Expert in Lung Cancer
26 reported clinical trials
65 drugs studied
About Marc Matrana, MD
Education:
- Earned an MD from Louisiana State University School of Medicine, New Orleans, in 2007.
- Completed Residency in Internal Medicine at Ochsner Clinic Foundation in 2010.
- Completed Fellowship in Hematology/Oncology at Ochsner Clinic Foundation in 2013.
Experience:
- Assistant Professor of Medicine at the University of Queensland School of Medicine – Ochsner Clinical School.
- Director of the Alvin J. Blumkin Center for Innovation and Research in Lung Cancer at Ochsner Health.
- Specializes in lung cancer and thoracic oncology.
Area of expertise
1Cancer
Global LeaderStage IV
Stage III
Stage II
2Lung Cancer
Global LeaderStage III
Stage II
Stage I
Affiliated Hospitals
Clinical Trials Marc Matrana, MD is currently running
Genetic Testing
for Early-Stage Lung Cancer
This ALCHEMIST trial studies genetic testing in screening patients with stage IB-IIIA non-small cell lung cancer that has been or will be removed by surgery. Studying the genes in a patient's tumor cells may help doctors select the best treatment for patients that have certain genetic changes.
Recruiting0 awards N/A4 criteria
Crizotinib
for Non-Small Cell Lung Cancer
This randomized phase III trial studies how well crizotinib works in treating patients with stage IB-IIIA non-small cell lung cancer that has been removed by surgery and has a mutation in a protein called anaplastic lymphoma kinase (ALK). Mutations, or changes, in ALK can make it very active and important for tumor cell growth and progression. Crizotinib may stop the growth of tumor cells by blocking the ALK protein from working. Crizotinib may be an effective treatment for patients with non-small cell lung cancer and an ALK fusion mutation.
Recruiting2 awards Phase 328 criteria
More about Marc Matrana, MD
Clinical Trial Related4 years of experience running clinical trials · Led 26 trials as a Principal Investigator · 12 Active Clinical TrialsTreatments Marc Matrana, MD has experience with
- Pembrolizumab
- Ipilimumab
- Nivolumab
- Docetaxel
- Pemetrexed Disodium
- Gemcitabine
Breakdown of trials Marc Matrana, MD has run
Cancer
Lung Cancer
Non-Small Cell Lung Cancer
Colorectal Cancer
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Marc Matrana, MD specialize in?
Marc Matrana, MD focuses on Cancer and Lung Cancer. In particular, much of their work with Cancer has involved Stage IV patients, or patients who are Stage III.
Is Marc Matrana, MD currently recruiting for clinical trials?
Yes, Marc Matrana, MD is currently recruiting for 11 clinical trials in New Orleans Louisiana. If you're interested in participating, you should apply.
Are there any treatments that Marc Matrana, MD has studied deeply?
Yes, Marc Matrana, MD has studied treatments such as Pembrolizumab, Ipilimumab, Nivolumab.
What is the best way to schedule an appointment with Marc Matrana, MD?
Apply for one of the trials that Marc Matrana, MD is conducting.
What is the office address of Marc Matrana, MD?
The office of Marc Matrana, MD is located at: Ochsner Medical Center Jefferson, New Orleans, Louisiana 70121 United States. This is the address for their practice at the Ochsner Medical Center Jefferson.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.